Protein ingestion acutely inhibits insulin-stimulated muscle carnitine uptake in healthy young men

American Journal of Clinical Nutrition

Volumn 103, Issue 1, 2016, Pages 276-282

  Shannon, Chris E ^a   Nixon, Aline V ^a   Greenhaff, Paul L ^a   Stephens, Francis B ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Doubly labeled water; Energy requirement; Resting energy expenditure; Short bowel syndrome; Total energy expenditure

Indexed keywords

ACYLCARNITINE; CARBOHYDRATE; CARNITINE; GLUCOSE; INSULIN; WHEY PROTEIN; CARBOHYDRATE DIET;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; AMINO ACID URINE LEVEL; ARTICLE; BEVERAGE; BLOOD FLOWMETRY; BLOOD SAMPLING; BODY MASS; CARBOHYDRATE INTAKE; CATION EXCHANGE; CHEMICAL ANALYZER; CONTROLLED STUDY; ECHOGRAPH; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN STIMULATED MUSCLE CARNITINE ACCRETION; MALE; MUSCLE BLOOD FLOW; MUSCLE METABOLISM; NORMAL HUMAN; PROTEIN INTAKE; SOLID PHASE EXTRACTION; STEADY STATE; YOUNG ADULT; ADMINISTRATION AND DOSAGE; AREA UNDER THE CURVE; ARM; BLOOD; CARBOHYDRATE DIET; CLINICAL TRIAL; DIET; DRUG EFFECTS; EATING; METABOLISM; REFERENCE VALUE; SKELETAL MUSCLE;

ADULT; AREA UNDER CURVE; ARM; BEVERAGES; CARNITINE; DIET; DIETARY CARBOHYDRATES; EATING; HUMANS; INSULIN; MALE; MUSCLE, SKELETAL; REFERENCE VALUES; WHEY PROTEINS; YOUNG ADULT;

EID: 84953898211     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.119826     Document Type: Article

References (49)

1. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008;7:45-56.
2. Keung W, Ussher JR, Jaswal JS, Raubenheimer M, Lam VH, Wagg CS, Lopaschuk GD. Inhibition of carnitine palmitoyltransferase-1 activity alleviates insulin resistance in diet-induced obese mice. Diabetes 2013; 62:711-20.
3. van Loon LJC, Greenhaff PL, Constantin-Teodosiu D, Saris WHM, Wagenmakers AJM. The effects of increasing exercise intensity on muscle fuel utilisation in humans. J Physiol 2001;536:295-304.
4. Stephens FB, Constantin-Teodosiu D, Laithwaite D, Simpson EJ, Greenhaff PL. An acute increase in skeletal muscle carnitine content alters fuel metabolism in resting human skeletal muscle. J Clin En-docrinol Metab 2006;91:5013-8.
5. Stephens FB, Wall BT, Marimuthu K, Shannon CE, Constantin-Teodosiu D, Macdonald IA, Greenhaff PL. Skeletal muscle carnitine loading increases energy expenditure, modulates fuel metabolism gene networks and prevents body fat accumulation in humans. J Physiol 2013;591: 4655-66.
6. Greenhaff PL, Campbell-O'Sullivan SP, Constantin-Teodosiu D, Poucher SM, Roberts PA, Timmons JA. An acetyl-group deficit limits mito-chondrial ATP production at the onset of exercise. Biochem Soc Trans 2002;30.
7. Wall BT, Stephens FB, Constantin-Teodosiu D, Marimuthu K, Macdonald IA, Greenhaff PL. Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans. J Physiol 2011; 589:963-73.
8. Calvert LD, Shelley R, Singh SJ, Greenhaff PL, Bankart J, Morgan MD, Steiner MC. Dichloroacetate enhances performance and reduces blood lactate during maximal cycle exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:1090-4.
9. Bauer TA, Regensteiner JG, Brass EP, Hiatt WR. Oxygen uptake kinetics during exercise are slowed in patients with peripheral arterial disease. J Appl Physiol 1999;87:809-16.
10. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, Tsuji A. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 1998;273:20378-82.
11. Wachter S, Vogt M, Kreis R, Boesch C, Bigler P, Hoppeler H, Krahenbuhl S. Long-term administration of L-carnitine to humans: effect on skeletal muscle carnitine content and physical performance. Clin Chim Acta 2002;318(1-2):51-61.
12. Vukovich MD, Costill DL, Fink WJ. Carnitine supplementation: effect on muscle carnitine and glycogen content during exercise. Med Sci Sports Exerc 1994;26:1122-9.
13. Brass EP, Hoppel CL, Hiatt WR. Effect of intravenous L-carnitine on carnitine homeostasis and fuel metabolism during exercise in humans. Clin Pharmacol Ther 1994;55:681-92.
14. Stephens FB, Constantin-Teodosiu D, Laithwaite D, Simpson EJ, Greenhaff PL. Insulin stimulates L-carnitine accumulation in human skeletal muscle. FASEB J 2006;20(2):377-9.
15. Steenge GR, Simpson EJ, Greenhaff PL. Protein-and carbohydrate-induced augmentation of whole body creatine retention in humans. J Appl Physiol 2000;89:1165-71.
16. Cermak NM, Res PT, de Groot LC, Saris WH, van Loon LJ. Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: a meta-analysis. Am J Clin Nutr 2012; 96:1454-64.
17. Liu D, Moberg E, Kollind M, Lins PE, Adamson U, Macdonald IA. Arterial, arterialized venous, venous and capillary blood glucose mea-surements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia. Diabetologia 1992;35:287-90.
18. Andres R, Zierler KL, Anderson HM, Stainsby WN, Cader G, Ghrayyib AS, Lilienthal JL Jr. Measurement of blood flow and volume in the forearm of man; with notes on the theory of indicator-dilution and on production of turbulence, hemolysis, and vasodilatation by in-tra-vascular injection. J Clin Invest 1954;33:482-504.
19. Gallen IW, Macdonald IA. Effect of two methods of hand heating on body temperature, forearm blood flow, and deep venous oxygen satu-ration. Am J Physiol 1990;259:E639-43.
20. Nilsson M, Holst JJ, Bjorck IM. Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks. Am J Clin Nutr 2007;85:996-1004.
21. Cederblad G, Lindstedt S. A method for the determination of carnitine in the picomole range. Clin Chim Acta 1972;37:235-43.
22. Hoskins PR. Measurement of arterial blood flow by Doppler ultrasound. Clin Phys Physiol Meas 1990;11:1-26.
23. Zierler KL. Theory of the use of arteriovenous concentration differ-ences for measuring metabolism in steady and non-steady states. J Clin Invest 1961;40:2111-25.
24. Tessari P, Inchiostro S, Biolo G, Vincenti E, Sabadin L. Effects of acute systemic hyperinsulinemia on forearm muscle proteolysis in healthy man. J Clin Invest 1991;88:27-33.
25. Wolfe RR, Chinkes DL. Isotope tracers in metabolic research: princi-ples and proctice of kinetic analysis. 2nd ed. Hoboken (NJ): John Wiley & Sons; 2005.
26. Stephens FB, Constantin-Teodosiu D, Laithwaite D, Simpson EJ, Greenhaff PL. A threshold exists for the stimulatory effect of insulin on plasma L-carnitine clearance in humans. Am J Physiol Endocrinol Metab 2007;292:E637-41.
27. Stephens FB, Evans CE, Constantin-Teodosiu D, Greenhaff PL. Carbohydrate ingestion augments L-carnitine retention in humans. J Appl Physiol 2007;102:1065-70.
28. Soop M, Bjorkman O, Cederblad G, Hagenfeldt L, Wahren J. Influence of carnitine supplementation on muscle substrate and carnitine metabolism during exercise. J Appl Physiol 1988;64:2394-9.
29. Schooneman MG, Ten Have GA, Van Vlies N, Houten SM, Deutz NE, Soeters MR. Transorgan fluxes in a porcine model reveal a central role for liver in acylcarnitine metabolism. Am J Physiol Endocrinol Metab 2015;309:E256-64.
30. Muoio DM, Noland RC, Kovalik JP, Seiler SE, Davies MN, DeBalsi KL, Ilkayeva OR, Stevens RD, Kheterpal I, Zhang J, et al. Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. Cell Metab 2012;15:764-77.
31. Seiler SE, Martin OJ, Noland RC, Slentz DH, DeBalsi KL, Ilkayeva OR, An J, Newgard CB, Koves TR, Muoio DM. Obesity and lipid stress inhibit carnitine acetyltransferase activity. J Lipid Res 2014;55:635-44.
32. Seiler SE, Koves TR, Gooding JR, Wong KE, Stevens RD, Ilkayeva OR, Wittmann AH, DeBalsi KL, Davies MN, Lindeboom L, et al. Carnitine acetyltransferase mitigates metabolic inertia and muscle fatigue during exercise. Cell Metab 2015;22:65-76.
33. Brass EP. Pharmacokinetic considerations for the therapeutic use of car-nitine in hemodialysis patients. Clin Ther 1995;17:176-85; discussion: 5.
34. Allwood MJ, Hensel H, Papenberg J. Muscle and skin blood flow in the human forearm during insulin hypoglycaemia. J Physiol 1959;147: 269-73.
35. Rebouche CJ, Engel AG. Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes: evidence for alterations in tissue carnitine transport. J Clin Invest 1984;73:857-67.
36. Ohashi R, Tamai I, Yabuuchi H, Nezu J-I, Oku A, Sai Y, Shimane M, Tsuji A. Na+-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther 1999;291:778-84.
37. Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PM. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med 1988;319:1331-6.
38. Stephens FB, Mendis B, Shannon CE, Cooper S, Ortori CA, Barrett DA, Mansell P, Tsintzas K. Fish oil omega-3 fatty acids partially prevent lipid-induced insulin resistance in human skeletal muscle without limiting acylcarnitine accumulation. Clin Sci (Lond) 2014; 127(5):315-22.
39. Adams SH, Hoppel CL, Lok KH, Zhao L, Wong SW, Minkler PE, Hwang DH, Newman JW, Garvey WT. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J Nutr 2009;139:1073-81.
40. Smith GI, Yoshino J, Stromsdorfer KL, Klein SJ, Magkos F, Reeds DN, Klein S, Mittendorfer B. Protein ingestion induces muscle insulin re-sistance independent of leucine-mediated mTOR activation. Diabetes 2015;64:1555-63.
41. Chen GJ, Russell JB. Sodium-dependent transport of branched-chain amino acids by a monensin-sensitive ruminal peptostreptococcus. Appl Environ Microbiol 1989;55:2658-63.
42. White MF, Gazzola GC, Christensen HN. Cationic amino acid transport into cultured animal cells. I. Influx into cultured human fibroblasts. J Biol Chem 1982;257:4443-9.
43. De Gaetano A, Mingrone G, Castagneto M, Calvani M. Carnitine increases glucose disposal in humans. J Am Coll Nutr 1999;18: 289-95.
44. Durán JM, Peral MJ, Calonge ML, Ilundain AA. Functional charac-terization of intestinal L-carnitine transport. J Membr Biol 2002;185: 65-74.
45. Taylor PM. Absorbing competition for carnitine. J Physiol 2001;532 (2):283.
46. Rebouche CJ, Chenard CA. Metabolic fate of dietary carnitine in human adults: identification and quantification of urinary and fecal metabolites. J Nutr 1991;121:539-46.
47. Hamilton JW, Li BU, Shug AL, Olsen WA. Carnitine transport in human intestinal biopsy specimens: demonstration of an active transport system. Gastroenterology 1986;91:10-6.
48. Li B, Lloyd ML, Gudjonsson H, Shug AL, Olsen WA. The effect of enteral carnitine administration in humans. Am J Clin Nutr 1992;55: 838-45.
49. Harper P, Elwin CE, Cederblad G. Pharmacokinetics of bolus in-travenous and oral doses of L-carnitine in healthy subjects. Eur J Clin Pharmacol 1988;35:69-75.